Post Feed

TSC research trial now recruiting in Australia

29 Jan 2024

The purpose of this ground-breaking research is to learn more about the safety and efficacy of early sirolimus treatment to prevent or delay seizure onset in infants diagnosed with TSC. Infants 0 to 6 months old who are diagnosed with TSC and have no history of seizures may be eligible to participate.

If needed, TSA can offer some assistance with travel and accommodation costs for families outside of Sydney, including interstate families who participate in the trial.